EXOR CAPITAL LLP
Q4 2023 Form 13-F

LONDON
CIK 0001732768 · CRD 324295 · SEC-registered investment adviser
Consolidated report · includes 2 managers since Q4 2017
$2.1B Reported Value Total

LINGOTTO INVESTMENT MANAGEMENT LLP reports 12 total accounts under management (AUM). There are 12 discretionary accounts valued at $6,632,479,049, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
4 funds · $2.6B gross asset value
Hedge Fund: $2.4B · Private Equity Fund: $205.8M
Source: Form ADV filed 2026-04-20
Reported value
$2.1B
Quarter over quarter
+5.5%
Holdings
34
Top-10 concentration
82.8%

Filing Structure

Reports holdings for

  • Exor N V · since Q4 2017
  • Giovanni Agnelli B.V. (not a 13F filer in our records) · since Q3 2024 · declared by one filing
  • EXOR NV (not a 13F filer in our records) · Q1 2018 – Q2 2024 · declared by one filing
  • Giovanni Agnelli BV (not a 13F filer in our records) · Q4 2021 – Q2 2024 · declared by one filing
  • Lingotto Invesment Management UK LTD (not a 13F filer in our records) · Q2 2024 – Q2 2024 · declared by one filing
  • Exor Investments Limited (not a 13F filer in our records) · Q2 2022 – Q1 2024 · declared by one filing
  • Lingotto Investment Management UK Ltd (not a 13F filer in our records) · Q4 2023 – Q4 2023 · declared by one filing
  • Lingtto Investment Management UK Ltd (not a 13F filer in our records) · Q3 2023 – Q3 2023 · declared by one filing
  • Lingotto Investment Management (UK) Limited (not a 13F filer in our records) · Q2 2023 – Q2 2023 · declared by one filing
  • Exor Investments LTD (not a 13F filer in our records) · Q4 2021 – Q3 2022 · declared by one filing

Key People

Form ADV owners & control persons
John Philip Elkann
MAJORITY SHAREHOLDER
Bon Man Heidi Ha
CHIEF OPERATING OFFICER
Loise Waithera Kabucho
CHIEF COMPLIANCE OFFICER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q4 2023 13F record

Q4 2023 13F filing summary

Q4 2023 Form 13F portfolio summary
Period of report December 31, 2023
Filed February 13, 2024
Form 13F-HR
Reported value $2.1B
Positions 34
Change in reported value +11.4%
New positions 6
Exited positions 5
Position turnover 28.2%
Top-10 concentration 82.8%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Oct 27, 2026
39 $5.7B
Q2 2026 13F
Filed Jul 29, 2026
31 $4.7B
Q1 2026 13F
Filed May 14, 2026
34 $5.1B
Q4 2025 13F
Filed Feb 10, 2026
38 $5.7B
Q3 2025 13F
Filed Nov 12, 2025
34 $5.4B
Q2 2025 13F
Filed Aug 13, 2025
42 $4.7B
Q1 2025 13F
Filed May 15, 2025
44 $3.8B
Q4 2024 13F
Filed Feb 4, 2025
53 $3.7B
Q3 2024 13F
Filed Nov 13, 2024
46 $3.5B
Q2 2024 13F
Filed Aug 12, 2024
50 $3.0B
Q1 2024 13F
Filed May 15, 2024
47 $2.4B
Q4 2023 13F
Filed Feb 13, 2024
34 $2.1B
Q3 2023 13F
Filed Nov 13, 2023
33 $1.9B
Q2 2023 13F
Filed Aug 11, 2023
33 $1.5B
Q1 2023 13F
Filed May 15, 2023
20 $1.4B
Q4 2022 13F
Filed Feb 15, 2023
18 $1.3B
Q3 2022 13F
Filed Nov 7, 2022
16 $1.1B
Q2 2022 13F
Filed Aug 12, 2022
16 $1.0B
Q1 2022 13F
Filed May 3, 2022
15 $1.5B
Q4 2021 13F
Filed Jan 18, 2022
18 $1.3B

16 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q4 2023

Largest Q4 2023 13F positions by reported value
# Holding Reported value % of portfolio
1 TEVA TEVA PHARMACEUTICAL INDS LTD $359.7M 17.32%
2 CVNA CARVANA CO $244.9M 11.79%
3 VAL VALARIS LTD $206.0M 9.91%
4 RRC RANGE RES CORP $193.5M 9.32%
5 HMY HARMONY GOLD MINING CO LTD $160.1M 7.71%
6 SLB SCHLUMBERGER LTD $147.4M 7.1%
7 GDXJ VANECK ETF TRUST $125.0M 6.02%
8 SBSW SIBANYE STILLWATER LTD $119.3M 5.74%
9 VEON VEON LTD $104.5M 5.03%
10 NG NOVAGOLD RES INC $58.7M 2.83%
11 PARA PARAMOUNT GLOBAL $48.4M 2.33%
12 MSFT MICROSOFT CORP $27.6M 1.33%
13 NXE NEXGEN ENERGY LTD $27.4M 1.32%
14 NVDA NVIDIA CORP $24.9M 1.2%
15 MRNA MODERNA INC $23.2M 1.12%
16 GATO GATOS SILVER INC $22.6M 1.09%
17 NOW SERVICENOW INC $21.3M 1.02%
18 MELI MERCADOLIBRE INC $20.5M 0.98%
19 RXRX RECURSION PHARMACEUTICALS $18.5M 0.89%
20 ISRG INTUITIVE SURGICAL INC $17.3M 0.83%

Values as reported on the Q4 2023 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings